Overview

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

Status:
Completed
Trial end date:
2016-07-11
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of gastric pH on acalabrutinib pharmacokinetics in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Acerta Pharma BV
Treatments:
Acalabrutinib